Pregnancy outcomes following false-positive multiple marker screening tests

American Journal of Perinatology

Volumn 14, Issue 8, 1997, Pages 475-478

  Chapman, Shelley J ^a,b   Brumfield, Cynthia G ^a   Wenstrom, Katharine D ^a   DuBard, Mary B ^a  

^a Division of Maternal Fetal Medicine   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Down's syndrome; Triple screen

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ERROR; DOWN SYNDROME; FEMALE; FETUS DEATH; FETUS ECHOGRAPHY; FETUS KARYOTYPING; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING TEST;

EID: 0030768881     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994183     Document Type: Article

References (18)

1. Haddow JE. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders. Semin Perinatol 1990;14:488-503
2. Merkatz IR, Nitowsky HM, Marcia JN, Johnson WE. An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148: 886-94
3. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987;7:623-30
4. Canick JA, Knight GJ, Palomaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second-trimester maternal serum unconjugated estriol in pregnancies with Down's syndrome. Br J Obstet Gynecol 1988;95:330-3
5. MacDonald ML, Wagner RM, Slotnick RN. Sensitivity and specificity of screening for Down's syndrome with alpha-fetoprotein, hCG, unconjugated estriol and maternal age. Obstet Gynecol 1991;77:63-8
6. Hamilton MP, Abdalla HI, Whitfield CR. Significance of raised maternal serum α-fetoprotein, in singleton pregnancies with normally formed fetuses. Obstet Gynecol 1985;65: 465-70
7. Maher JE, Davis RO, Goldenberg RL, Boots LR, DuBard MB. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss. Obstet Gynecol 1994;138:41
8. Waller DK, Lustig LS, Cunningham GC, Golbus MS, Hook EB. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med 1991;325:6-10
9. Burton BD. Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein. Obstet Gynecol 1988;72:709-12
10. Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992;327:588-93
11. Wenstrom KD, Williamson RA, Grant SS, Hudson JD, Getchell JP. Evaluation of multiple-marker screening for Down's syndrome in a statewide population. Am J Obstet Gynecol 1993;169:793-7
12. Brenner WE, Edelman DA, Hendricks CH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976;126:555-64
13. New England Regional Genetics Group Prenatal Collaborative Study of Down Syndrome Screening. Combining maternal serum α-fetoprotein measurements and age to screen for fetal Down's syndrome in pregnant women under age 35. Am J Obstet Gynecol 1989;160:175-9
14. Wald NJ, Cuckle HS, Denserm JW, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297:883-7
15. Pergament E, Stein AK, Fiddler M, Cho NH, Kupfermine MJ. Adverse pregnancy outcome after a false positive screen for Down's syndrome using Multiple Markers. Obstet Gynecol 1995;86:255-8
16. Lieppman RE, Williams MA, Cheng EY, et al. An association between elevated levels of human chorionic gonadotropin in the mid-trimester and adverse pregnancy outcome. AM J Obstet Gynecol 1993;168:1852-7
17. Wenstrom KD, Owen J, Boots LR, DuBard MB. Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome. Am J Obstet Gynecol 1994;171:1038-41
18. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC III. Williams Obtetrics, 19th ed. Norwalk, Connecticut: Appleton & Lange; 1993: pp 656-8